Financials data is unavailable for this security.
View more
Year on year Dr Martens PLC 's revenues fell -12.32% from 1.00bn to 877.10m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 128.90m to 69.20m, a -46.31% decrease.
| Gross margin | 65.58% |
|---|---|
| Net profit margin | 7.89% |
| Operating margin | 13.93% |
| Return on assets | 7.12% |
|---|---|
| Return on equity | 17.92% |
| Return on investment | 8.51% |
More ▼
Cash flow in GBPView more
In 2024, cash reserves at Dr Martens PLC fell by 46.40m. However, the company earned 167.90m from its operations for a Cash Flow Margin of 19.14%. In addition the company used 25.50m on investing activities and also paid 185.90m in financing cash flows.
| Cash flow per share | 0.1436 |
|---|---|
| Price/Cash flow per share | 4.31 |
| Book value per share | 0.383 |
|---|---|
| Tangible book value per share | 0.1021 |
More ▼
Balance sheet in GBPView more
| Current ratio | 2.85 |
|---|---|
| Quick ratio | 1.19 |
| Total debt/total equity | 1.27 |
|---|---|
| Total debt/total capital | 0.56 |
More ▼
Growth rates in GBP
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -56.34% and -45.47%, respectively. Additionally, five year annualized earnings per share growth ranks highest in its industry.
| Div yield(5 year avg) | 1.86% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 35.40% |
| EPS growth(5 years) | 32.49 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -44.99 |
More ▼
